Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia: a phase 3 study - Braess, Jan; Lengfelder, Eva; Uppenkamp, Michael; Lablans, Martin (Leukemia, 2018)
Gesehen am 05.02.2019